000 | 03222nam a2200397 a 4500 | ||
---|---|---|---|
001 | EBC938848 | ||
003 | MiAaPQ | ||
005 | 20240120133610.0 | ||
006 | m o d | | ||
007 | cr cn||||||||| | ||
008 | 111025s2012 njua sb 001 0 eng d | ||
010 | _z 2011044253 | ||
020 | _z9780470878279 (cloth) | ||
020 | _a9781118274378 (electronic bk.) | ||
035 | _a(MiAaPQ)EBC938848 | ||
035 | _a(Au-PeEL)EBL938848 | ||
035 | _a(CaPaEBR)ebr10580300 | ||
035 | _a(CaONFJC)MIL367371 | ||
035 | _a(OCoLC)802068199 | ||
040 |
_aMiAaPQ _cMiAaPQ _dMiAaPQ |
||
050 | 4 |
_aRS100 _b.D78 2012 |
|
082 | 0 | 4 |
_a338.4/76151 _223 |
245 | 0 | 0 |
_aDrug repositioning _h[electronic resource] : _bbringing new life to shelved assets and existing drugs / _cedited by Michael J. Barratt, Donald E. Frail. |
260 |
_aHoboken : _bJohn Wiley & Sons, _cc2012. |
||
300 |
_axx, 477 p. : _bill. |
||
504 | _aIncludes bibliographical references and index. | ||
505 | 0 | _aDrug repositioning : the business case and current strategies to repurpose shelved candidates and marketed drugs / John Arrowsmith and Richard Harrison -- Opportunities and challenges associated with developing additional indications for clinical development candidates and marketed drugs / Donald Frail and Michael Barratt -- Clinical and operational considerations in repositioning marketed drugs and drug candidates / Damian O'Connell, David Sequeira, and Maria Miller -- Regulatory considerations and strategies for drug repositioning / Ken Phelps -- Computational and bioinformatic strategies for drug repositioning / Richard Mazzarella and Craig Webb -- Mining scientific and clinical databases to identify novel uses for existing drugs / Christos Andronis ... [et al.] -- Predicting the polypharmacology of drugs : identifying new uses through chemoinformatics, structural informatics and molecular modeling based approaches / Li Xie ... [et al.] -- Systematic phenotypic screening for novel synergistic combinations: a new paradigm for repositioning existing drugs / Margaret Lee -- Phenotypic in vivo screening to identify new, unpredicted indications for existing drugs and drug candidates / Michael Saporito, Christopher Lipinski, and Andrew Reaume -- Old drugs yield new discoveries : examples from the prodrug, chiral switch and site-selective deuteration strategies / Adam Morgan ... [et al.] -- Repurposing drugs for tropical diseases : case studies and open-source screening initiatives / Curtis Chong -- Drug repositioning efforts by non-profit foundations -- Business development strategies in the repositioning industry / Aris Persidis and Elizabeth Stark -- A case study in drug repositioning : Sosei / Akinori Mochizuki and Makiko Aoyama. | |
533 | _aElectronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. | ||
650 | 0 |
_aPharmaceutical industry _xEconomic aspects. |
|
650 | 0 |
_aDrugs _xEconomic aspects. |
|
655 | 4 | _aElectronic books. | |
700 | 1 | _aBarratt, Michael J. | |
700 | 1 | _aFrail, Donald. | |
710 | 2 | _aProQuest (Firm) | |
856 | 4 | 0 |
_uhttps://ebookcentral.proquest.com/lib/bacm-ebooks/detail.action?docID=938848 _zClick to View |
999 |
_c79820 _d79820 |